Gastrointestinal eosinophils in health and disease - PubMed (original) (raw)
Review
Gastrointestinal eosinophils in health and disease
M E Rothenberg et al. Adv Immunol. 2001.
No abstract available
Similar articles
- Gastrointestinal eosinophils.
Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Rothenberg ME, et al. Immunol Rev. 2001 Feb;179:139-55. doi: 10.1034/j.1600-065x.2001.790114.x. Immunol Rev. 2001. PMID: 11292017 Review. - Fundamental signals that regulate eosinophil homing to the gastrointestinal tract.
Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. Mishra A, et al. J Clin Invest. 1999 Jun;103(12):1719-27. doi: 10.1172/JCI6560. J Clin Invest. 1999. PMID: 10377178 Free PMC article. - Cellular and molecular regulation of eosinophil trafficking to the lung.
Hogan SP, Mould AW, Young JM, Rothenberg ME, Ramsay AJ, Matthaei K, Young IG, Foster PS. Hogan SP, et al. Immunol Cell Biol. 1998 Oct;76(5):454-60. doi: 10.1046/j.1440-1711.1998.00766.x. Immunol Cell Biol. 1998. PMID: 9797467 - Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues.
Rothenberg ME. Rothenberg ME. Am J Respir Cell Mol Biol. 1999 Sep;21(3):291-5. doi: 10.1165/ajrcmb.21.3.f160. Am J Respir Cell Mol Biol. 1999. PMID: 10460744 Review. No abstract available. - Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD. Rothenberg ME, et al. Mol Med. 1996 May;2(3):334-48. Mol Med. 1996. PMID: 8784786 Free PMC article.
Cited by
- Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis.
Yadavalli CS, Upparahalli Venkateshaiah S, Verma AK, Kathera C, Duncan PS, Vaezi M, Paul RJ, Mishra A. Yadavalli CS, et al. Cells. 2024 Feb 6;13(4):295. doi: 10.3390/cells13040295. Cells. 2024. PMID: 38391908 Free PMC article. - Allergen-induced NLRP3/caspase1/IL-18 signaling initiate eosinophilic esophagitis and respective inhibitors protect disease pathogenesis.
Yadavalli CS, Upparahalli Venkateshaiah S, Kumar S, Kandikattu HK, Oruganti L, Kathera CS, Mishra A. Yadavalli CS, et al. Commun Biol. 2023 Jul 31;6(1):763. doi: 10.1038/s42003-023-05130-4. Commun Biol. 2023. PMID: 37524769 Free PMC article. - Long term Th2 cytokines immunotherapy beneficial for EoE pediatric patients?
Mishra A. Mishra A. Int J Public Health Aware. 2022;5(1-2):9-11. Epub 2022 Jul 26. Int J Public Health Aware. 2022. PMID: 36212388 Free PMC article. - Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease.
Gabriëls RY, Bourgonje AR, von Martels JZH, Blokzijl T, Weersma RK, Galinsky K, Juarez J, Faber KN, Kats-Ugurlu G, Dijkstra G. Gabriëls RY, et al. J Clin Med. 2022 Jul 16;11(14):4141. doi: 10.3390/jcm11144141. J Clin Med. 2022. PMID: 35887905 Free PMC article. - Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.
Khokhar D, Marella S, Idelman G, Chang JW, Chehade M, Hogan SP. Khokhar D, et al. Clin Exp Allergy. 2022 Oct;52(10):1142-1156. doi: 10.1111/cea.14196. Epub 2022 Jul 19. Clin Exp Allergy. 2022. PMID: 35778876 Free PMC article. Review.